Aldeyra Therapeutics Inc (ALDX)
3.94
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
3.94
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Total Liabilities (Quarterly): 28.53M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.53M |
| September 30, 2023 | 24.27M |
| June 30, 2023 | 25.73M |
| March 31, 2023 | 30.98M |
| December 31, 2022 | 30.28M |
| September 30, 2022 | 27.50M |
| June 30, 2022 | 26.99M |
| March 31, 2022 | 32.00M |
| December 31, 2021 | 27.40M |
| September 30, 2021 | 27.55M |
| June 30, 2021 | 22.75M |
| March 31, 2021 | 21.23M |
| December 31, 2020 | 23.84M |
| September 30, 2020 | 19.15M |
| June 30, 2020 | 18.84M |
| March 31, 2020 | 19.56M |
| December 31, 2019 | 27.44M |
| September 30, 2019 | 26.56M |
| June 30, 2019 | 6.506M |
| March 31, 2019 | 9.648M |
| December 31, 2018 | 8.473M |
| September 30, 2018 | 8.536M |
| Date | Value |
|---|---|
| June 30, 2018 | 6.305M |
| March 31, 2018 | 4.775M |
| December 31, 2017 | 4.574M |
| September 30, 2017 | 3.324M |
| June 30, 2017 | 3.128M |
| March 31, 2017 | 3.537M |
| December 31, 2016 | 3.538M |
| September 30, 2016 | 3.520M |
| June 30, 2016 | 3.366M |
| March 31, 2016 | 2.910M |
| December 31, 2015 | 3.326M |
| September 30, 2015 | 2.655M |
| June 30, 2015 | 2.353M |
| March 31, 2015 | 2.105M |
| December 31, 2014 | 2.503M |
| September 30, 2014 | 2.087M |
| June 30, 2014 | 1.990M |
| March 31, 2014 | 4.027M |
| December 31, 2013 | 5.647M |
| September 30, 2013 | 14.58M |
| December 31, 2012 | 27.13M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.506M
Minimum
Jun 2019
32.00M
Maximum
Mar 2022
24.58M
Average
26.56M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
| AbbVie Inc | 124.31B |
| United Therapeutics Corp | 1.182B |
| Heron Therapeutics Inc | 256.48M |
| Esperion Therapeutics Inc | 660.79M |
| FibroGen Inc | 585.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.33M |
| Shareholders Equity (Quarterly) | 119.80M |